Holocene Advisors
RVNC

Holocene Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Holocene Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-842,563
Closed -$21.3M – 907
2023
Q2 		$21.3M Sell
842,563
-93,852
-10% -$2.92M 0.09% 205
2023
Q1 		$30.2M Sell
936,415
-370,245
-28% -$11.5M 0.15% 171
2022
Q4 		$24.1M Buy
1,306,660
+240,698
+23% +$5.51M 0.15% 163
2022
Q3 		$28.8M Buy
+1,065,962
New +$21.6M 0.18% 152

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return